CHEMILOGIC Trademark

Trademark Overview


On Friday, September 2, 2022, a trademark application was filed for CHEMILOGIC with the United States Patent and Trademark Office. The USPTO has given the CHEMILOGIC trademark a serial number of 97576906. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, October 17, 2024. This trademark is owned by Empress Therapeutics, Inc.. The CHEMILOGIC trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals containing small molecules for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; pharmaceutical preparations and therapeutic agents for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders

Pharmaceutical drug development services; scientific research, namely, research and analysis services in the fields of pharmaceuticals and biotechnology for the design and characterization of biologic therapeutic products; pharmaceutical and biotechnology research and development
chemilogic

General Information


Serial Number97576906
Word MarkCHEMILOGIC
Filing DateFriday, September 2, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, October 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements


Goods and ServicesPharmaceuticals containing small molecules for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; pharmaceutical preparations and therapeutic agents for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
Goods and ServicesPharmaceutical drug development services; scientific research, namely, research and analysis services in the fields of pharmaceuticals and biotechnology for the design and characterization of biologic therapeutic products; pharmaceutical and biotechnology research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 19, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEmpress Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameEmpress Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Wednesday, September 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 20, 2023ASSIGNED TO EXAMINER
Wednesday, June 21, 2023NON-FINAL ACTION WRITTEN
Wednesday, June 21, 2023NON-FINAL ACTION E-MAILED
Wednesday, June 21, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 11, 2024SOU EXTENSION 1 FILED
Thursday, April 11, 2024SOU EXTENSION 1 GRANTED
Thursday, April 11, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 17, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 17, 2024SOU EXTENSION 2 GRANTED
Thursday, October 17, 2024SOU EXTENSION 2 FILED